Empresa Evogene Ltd Other OTC
Acciones
IL0011050551
Biotecnología e investigación médica
Precio de cierre
Otros sitios de cotización
|
||
- USD | - |
|
23/05 | Evogene Ltd. Proporciona orientación de ingresos para el año 2024 | CI |
23/05 | Transcript : Evogene Ltd., Q1 2024 Earnings Call, May 23, 2024 |
Resumen de negocios
Ventas por actividad
USD en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Agriculture
67,2
%
| 1 | 52,3 % | 4 | 67,2 % | +332,76 % |
Industrial Applications
19,1
%
| 0 | 4,3 % | 1 | 19,1 % | +1.393,06 % |
Human Health
8,6
%
| 1 | 30,6 % | 0 | 8,6 % | -5,07 % |
Unallocated
5,1
%
| 0 | 12,8 % | 0 | 5,1 % | +34,11 % |
Ventas por región
USD en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
United States
65,0
%
| 1 | 51,0 % | 4 | 65,0 % | +329,15 % |
Others
19,0
%
| 0 | 4,0 % | 1 | 19,0 % | +1.499,40 % |
Israel
16,0
%
| 1 | 45,0 % | 1 | 16,0 % | +19,72 % |
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
Ofer Haviv
CEO | Chief Executive Officer | 58 | 01/01/02 |
Yaron Eldad
DFI | Director of Finance/CFO | 57 | 01/04/22 |
Mark Kapel
CTO | Chief Tech/Sci/R&D Officer | 48 | 01/01/05 |
Eyal Ronen
PRN | Corporate Officer/Principal | - | 01/06/22 |
Sassi Masliah
PRN | Corporate Officer/Principal | - | 01/01/11 |
Human Resources Officer | - | 01/01/15 | |
Nir Arbel
PRN | Corporate Officer/Principal | - | 01/08/21 |
Yisrael Gewirtz
AUD | Comptroller/Controller/Auditor | 47 | - |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Dan Falk
BRD | Director/Board Member | 79 | 17/11/21 |
Sarit Firon
CHM | Chairman | 58 | 11/08/16 |
Leon Recanati
BRD | Director/Board Member | 76 | 01/05/05 |
Ofer Haviv
CEO | Chief Executive Officer | 58 | 01/01/02 |
Oded Shoseyov
BRD | Director/Board Member | 67 | 01/11/18 |
Nir Nimrodi
BRD | Director/Board Member | 55 | 01/09/22 |
Adrian Percy
BRD | Director/Board Member | 59 | 04/02/19 |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 1 | 50 584 888 | 49 746 029 ( 98,34 %) | 0 | 98,34 % |
Información de la empresa
![Dirección Evogene Ltd](https://cdn.zonebourse.com/static/address/2226993.png)
Sector
Ventas por actividad
Ventas por región
Varia. 1 de ene. | Capi. | |
---|---|---|
+38,65 % | 39,1 mil M | |
-8,62 % | 38,76 mil M | |
+26,95 % | 31,24 mil M | |
+10,74 % | 25,9 mil M | |
-13,50 % | 25,8 mil M | |
+44,87 % | 14,06 mil M | |
+34,36 % | 13,12 mil M | |
-7,14 % | 11,32 mil M | |
-12,61 % | 10,68 mil M |
- Bolsa de valores
- Acciones
- Acción EVGN
- Acción
- Empresa Evogene Ltd